Q2i Secures Patent for PARCA Solution, Revolutionizing Probation and Parole
McDermott Appoints Krist Werling to Lead Best-In-Class Global Health & Life Sciences Practice
DeepScribe receives 98.8* overall performance score in KLAS Research report, with top grades in every category
GlobalVetLink Unveils New HorseSync Progressive Web Application to Support Streamlined Workflows for Equine Veterinary Clinics
Arbital Health Expands Value-Based Care Contracting Capabilities with Acquisition of Senior Actuary Team
Key preclinical milestone for novel, non-opioid extended-release pain therapeutic SARASOTA, FL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Oracle Health partnership enables 400-bed Texas-based health system to leverage RevID’s automated charge reconciliation to improve financial performanceATLANTA, Dec. 18,...
Partnership leverages proprietary PHICS™ technology to bring together a kinase and target of interest to modulate protein function, in this...
Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile Data includes complete results from cohort 1...
- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials...
FREDERICK, Md., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering...
NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational...
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform...
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel...
CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate...
Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi has...
TORONTO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Redecan Cannabis, a leading brand under Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a...
Company debt reduced by $194 millionCash position after closing will be in excess of $180 million DANBURY, Conn. and WESTLAKE...
ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to phase II for dose finding...
Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop globally accessible in vivo genetic...
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer...
– $75 million equity financing at $0.625 per Vireo share will result in combined new entity having an industry-leading balance...
SAN JUAN CAPISTRANO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group...
BRUSSELS, Dec. 18, 2024 (GLOBE NEWSWIRE) -- European Bioplastics (EUBP) welcomes the adoption of the European Union’s ambitious Packaging and...
